GINGER CONKLIN: Open Payments
NPI 1265919468 · ABERDEEN, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 5 payments from 4 companies in 2025. Trend: 2023 $255 · 2024 $127 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $66 |
| Phathom Pharmaceuticals, Inc. | 1 | $65 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: LYBALVI, VOQUEZNA, Qelbree, CAPLYTA.
Industry payments across SD — which companies pay providers there.
